1. The document is a mid-term exam for a pharmacology course containing 23 multiple choice questions covering various pharmacology topics such as drug metabolism, pharmacokinetics, pharmacodynamics, and drug interactions.
2. Question topics include drug tolerance, hepatic drug metabolism, drug half-life, bioavailability, drug efficacy, pharmacogenetics, drug antagonism, and therapeutic indices.
3. The questions assess understanding of key pharmacology concepts like drug dosing, metabolism, distribution, elimination, mechanisms of action, variability in drug responses, and factors influencing these processes.
1. The document is a mid-term exam for a pharmacology course containing 23 multiple choice questions covering various pharmacology topics such as drug metabolism, pharmacokinetics, pharmacodynamics, and drug interactions.
2. Question topics include drug tolerance, hepatic drug metabolism, drug half-life, bioavailability, drug efficacy, pharmacogenetics, drug antagonism, and therapeutic indices.
3. The questions assess understanding of key pharmacology concepts like drug dosing, metabolism, distribution, elimination, mechanisms of action, variability in drug responses, and factors influencing these processes.
1. The document is a mid-term exam for a pharmacology course containing 23 multiple choice questions covering various pharmacology topics such as drug metabolism, pharmacokinetics, pharmacodynamics, and drug interactions.
2. Question topics include drug tolerance, hepatic drug metabolism, drug half-life, bioavailability, drug efficacy, pharmacogenetics, drug antagonism, and therapeutic indices.
3. The questions assess understanding of key pharmacology concepts like drug dosing, metabolism, distribution, elimination, mechanisms of action, variability in drug responses, and factors influencing these processes.
1. The document is a mid-term exam for a pharmacology course containing 23 multiple choice questions covering various pharmacology topics such as drug metabolism, pharmacokinetics, pharmacodynamics, and drug interactions.
2. Question topics include drug tolerance, hepatic drug metabolism, drug half-life, bioavailability, drug efficacy, pharmacogenetics, drug antagonism, and therapeutic indices.
3. The questions assess understanding of key pharmacology concepts like drug dosing, metabolism, distribution, elimination, mechanisms of action, variability in drug responses, and factors influencing these processes.
Subject: Pharmacology Course Instructor: Dr. Maryam
Total marks: 50
1. A patient complaints of reduction in the is doubled, what response in the steady
improvement of symptoms and shows state concentration will be expected? rapidly diminishing response to a drug a. Decrease by 50% on repeated administration at frequent b. Doubled intervals. Which of the following terms c. Increase by 50% best describes this phenomenon? d. Increase by 4 times a. Anaphylaxis e. Remain unchanged b. Hyposensitivity 5. A patient is given a drug which c. Supersensitivity. undergoes biotransformation by hepatic d. Tachyphylaxis enzymes to be converted to polar form. e. Tolerance Which one of the following is not a 2. A drug when administered in the body phase II hepatic metabolic reaction? undergoes pharmacokinetic changes. a. Acetylation Which of the following does not occur b. Glucuronidation after drug metabolism? c. Hydrolysis a. Decreased time of action of the d. Methylation drug e. Sulfation b. Increased polarity of the drug. 6. Drug A has a half-life of 10 hours. If it is c. Increased ionization of the drug administered by continuous I.V. infusion d. Increased time of action of the to a patient, how long will it take Drug A drug to reach 75% of its steady state e. Increased renal excretion of the concentration? drug a. 10 hours 3. A drug is administered in the body by severel routes. Which of the following b. 20 hours routes cannot avoid hepatic first pass c. 25 hours metabolism? a. Intramuscular d. 30 hours e. 50 Hours b. Intravenous 7. A drug produces its maximum effect and c. Rectal relieves the pain. The maximum effect d. Sublingual (E max) achieved by a drug is a e. Transdermal measure of which of the following? 4. A drug X is given by intravenous a. Efficacy infusion. If the rate of infusion of a drug b. Potency and thus decrease the bioavailability of c. Quantal Response the affected drug: d. Receptor Affinity a. Anti-tubercular drugs e. Therapeutic Index b. Broad-spectrum antibiotics 8. Which of the following is calculated as the ratio of the area under the curve c. Anti-cancer antibiotics (AUC) obtained by oral administration d. Anti-retroviral drugs vs. the AUC for intravenous e. Systemic anti-fungal drugs administration of the same drug? 13. Which of the following clinical a. Absorption situations in a patient, is unlikely to b. Bioavailability increase the half-life of a drug? c. Clearance a. Congestive cardiac failure d. Extraction e. Volume of distribution b. Increase volume of 9. A patient shows a qualitatively abnormal distribution harmful response to a drug which is c. Decreased volume of unpredictable, not related with dose and distribution is not related with immune system. It is d. Impairment of hepatic thought to be because of genetic function predisposition. This is called: e. Impairment of the Kidney a. Idiosyncrasy function b. Pharmacogenetics 14. Which of the following most accurately c. Anaphylaxis describes the transmembrane signaling process involved in the action of insulin? d. Tachyphylaxis a. Activates adenylate cyclase e. Tolerance through GPCRs 10. Adrenaline is a life saving drug in the treatment of anaphylaxis. Reversal of b. Activates on tyrosine kinase histamine induced bronchospasm and linked receptors vasodilation by adrenaline is due to: c. Binding & activation of a. Physiological antagonism intracellular receptors b. Pharmacological antagonism d. Diffusion of STATs across the c. Chemical antagonism cell membrane d. Competitive antagonism e. Opening of ion channels e. None Competitive antagonism 11. Study of biochemical and physiological involving Na+ & K+ effects of drugs as well as their 15. Which of the following provides mechanism of action is dealt with by information about the variation in the which branch of Pharmacology? effectiveness of a drug within the a) Pharmacokinetics population studied? b) Pharmacoepidemiology a. Potency of the drug c) Clinical pharmacology b. Graded dose response curve d) Pharmacogenomics c. Maximal efficacy of the drug e) Pharmacodynamics d. Therapeutic index of the drug 12. Which of the following drugs can e. Quantal dose response curve interfere with enterohepatic recycling 16. A patient undergoes decreasing response 20. Epinephrine is a life saving drug when to a drug on repeated administration, but used in anaphylactic shock. It the same response can be achieved by counteracts the harmful effects of released histamine by which of the increasing the dose of the drug. This following types of antagonism? phenomenon is termed as: a. Chemical antagonism a. Photosensitivity b. Pharmacological b. Tachyphylaxis antagonism c. Drug allergy c. Pharmacokinetic d. Drug dependence antagonism e. Tolerance d. Physiological antagonism 17. Therapeutic window is a clinically e. Physical antagonism useful parameter to determine the safety 21. A nonvolatile highly lipid soluble drug is margin of a drug. It is calculated as a metabolized at a rate of 15% per hour. ratio of: On IV injection it produces general a. Maximum toxic & minimum anesthesia only for 10 min. Which effective dose process is responsible for quick b. Median lethal dose & median termination of its action? a. Metabolism in the liver effective dose b. Plasma protein binding c. Minimum toxic & minimum c. Excretion by the kidneys effective dose d. Redistribution of drug d. Minimum toxic & maximum e. Lipid solubility of drug effective dose 22. The study of biochemical and e. Maximum toxic &maximum physiological effect of drugs as well as their mechanism of action is dealt with effective dose by which branch of Pharmacology? 18. A 63 years old patient in intensive care a. Pharmacokinetics unit requires infusion of procainamide. b. Pharmacoepidemiology Its half life is 2 hrs. The infusion begins c. Clinical pharmacology at 9 AM in the morning. What %age of d. Pharmacogenomics steady state plasma concentration will be e. Pharmacodynamics reached at 3 pm on the same day? 23. Which of the following is the branch of a. 75 % pharmacology which deals with the b. 50 % doses of drugs? c. 93 % a. Chemotherapy d. 87 % b. Therapeutics e. 100 % c. Pharmacy 19. In addition to slow intravenous infusion, d. Pharmacokinetic which of the following routes of drug s administration allows for titration of the e. Posology dose of a drug with the response? 24. Alkaloids are important active principal a. Sublingual of drugs coming from natural plant b. Transdermal source. Which of the following is an c. Inhalational important feature of an alkaloid? d. Nasal insufflation a. Soluble in e. Subcutaneous alcohol b. Non-nitrogenous receptors. Which of the following terms comp describes a characteristic of loratadine c. Acidic in binding to the H1 receptor? reaction a. Intrinsic activity d. Soluble in water b. Potency e. Biologically c. Maximal efficacy inactive d. Affinity 25. If a drug has got a very large volume of e. Receptor activation distribution, which of the following 29. A 65 year old woman suffering from properties can be present in this atrial fibrillation had been taking a drug particular drug? to treat this condition for 6 months. The a. It has got very high water drug had no intrinsic activity and bound solubility reversibly to β1 receptors. Which of the b. It is a strongly ionized polar following terms best defines this drug? drug a. Partial agonist c. It is a lipid soluble b. Inverse agonist compound c. Irreversible antagonist d. Lipid soluble with tissue d. Competitive antagonist binding e. Agonist - Antagonist e. A quaternary ammonium 30. A 50 years old female was taking compound propranolol, a beta adrenergic blocker, 26. A 12 year old boy recently diagnosed for the last two years. Her physician with type 1 diabetes started a therapy switches her to an ACE inhibitor. Two with twice daily subcutaneous days later she was received in administration of insulin. Which of the emergency with acute attack of angina. following permeation processes best Which of the following may be most explains the absorption of insulin from likely cause? the site of s/c injection? a. Receptor desensitization. a. Bulk flow transport b. Receptor down regulation b. Lipid diffusion c. Receptor up regulation c. Facilitated diffusion d. Activation of spare d. Endocytosis receptors e. Active transport e. Temporal sparseness of 27. A 22 year old man suffering from autism receptors and violent behavior started a treatment 31. A patient shows rapidly diminishing that included buspirone, a drug with a response to a drug on repeated large first – pass effect. Which of the administrations of this drug at frequent following pharmacokinetic properties of intervals. This phenomenon is called: drug was most likely affected by this a. Hypersensitivity large first-pass effect? a. Volume of distribution b. Tolerance b. Oral bioavailability c. Supersensitivity c. Renal clearance d. Sublingual bioavailability d. Tachyphylaxis e. Intramuscular bioavailability e. Idiosyncrasy 28. A 14 year old suffering from seasonal 32. Which of the following parameter is rhinitis started a therapy with loratadine, calculated as the ratio of the area under a drug that binds to H1 histamine the plasma concentration versus time curve (AUC) obtained by oral d. Concentration gradient administration vs. the AUC after e. Nature of the drug intravenous administration of the same 37. An elderly patient has problem remembering drug? to take her medication three times a day. f. Absorption Which one of the drug formulations might g. Bioavailability be particularly useful in this case? h. Clearance a. Extended-release i. Elimination rate b. Suspension j. Extraction ratio c. Suppository 33. After binding to a proteinaceous d. Skin-patch membrane carrier, drugs are transported e. Enteric-coated across the body membranes against the 38. If food decreases the rate but not extent of concentration gradient with the the absorption of a particular drug from the expenditure of cellular energy, where gastrointestinal tract, then taking the drug they are released. Which of the with food will result in a smaller. following process is involved in such transport? a. Area under the plasma a. Filtration drug concentration time b. Simple diffusion curve c. Facilitated diffusion b. Maximal plasma drug d. Active transport concentration e. Endocytosis c. Time at which the 34. Hepatic biotransformation reactions that maximal plasma drug unmask or introduce a functional group concentration occurs like OH, NH2, or SH, are known as d. Fractional which of the following? bioavailability a. Conjugations e. Total clearance b. Glucuronidations 39. After a person ingests an overdose of an c. Phase 1reactions opioid analgesic, the plasma drug d. Phase 2 reactions concentration is found to be 32 mg/L. How e. Synthetic reactions long will it take to reach a safe plasma 35. Pick out the appropriate alimentary route of concentration of 2 mg/L if the drug’s half administration when passage of drugs life is 6 hours? through liver is minimized: a. Oral a. 12 hours b. Transdermal b. 24 hours c. Rectal c. 48 hours d. Intraduodenal d. 72 hours e. Non of the above e. 1 Week 36. Most of the drugs are absorbed from GIT 40. We start intravenous infusion of a drug after oral administration by the process of using an infusion pump to ensure that the passive diffusion. The transmembrane rate of drug delivery is constant over time. permeation of drugs through this process is What one factor determines how long it will inversely related to which of the following? take for the drug to reach a steady-state a. Lipid solubility concentration (Css) in the blood? b. Permeability coefficient a. Apparent volume of of the drug distribution c. Thickness of the b. Bioavailability membrane c. Clearance and bioavailability are known, what would d. Half-life one need to know? e. Infusion rate (mg of a. Rate of drug clearance drug/min) 41. A patient is given a non competitive b. Plasma half-Life of drug irreversible antagonist followed by c. Rate of drug Infusion administration of increasing doses of agonist. In the presence of the non d. Volume of Distribution competitive irrervsible antagonist the e. Rate of drug metabolism agonist’s 45. A drug with a half-life of 10 hours is a. Potency is increased administered by continuous intravenous b. Maximum efficacy is infusion. Which of the following best increased approximates the time for the drug to reach c. Ed50 is increased steady state? d. Ed50 is decreased a. 10 hours e. Affinity is decreased b. 20 hours 42. In the presence of drug A, higher c. 33 hours concentration of drug B is required to elicit d. 40 hours full pain relief. Drug A has less analgesic e. 60 hours. effect than does drug B even at the highest 46. Elimination of drugs via the kidneys into dose. So the drug A can be labeled as: urine involves the processes of glomerular a. Competitive antagonist filteration, active tubular secretion and of drug B _________. b. Drug A is the partial a. Passive tubular agonist reabsorption c. Drug B is less b. Active tubular reabsorption efficacious than drug A c. Active tubular d. Drug B is less potent redistribution than drug A d. Passive tubular e. Drug A is a non redistribution competitive antagonist e. Loop of henle secretion 43. Nitroglycerine is a drug administered sublingually to terminate an attack of angina 47. Most important route of drug elimination is Which of the following is an advantage of through which of the following organ: sublingual route of administration? a. Blood a. It has no risk of first pass b. Bile metabolism c. Kidney b. It is suitable for all age d. Breast milk groups of pts e. Lungs c. It can be used in 48. Variation in the sensitivity of a population of unconscious patient individuals to increasing doses of a drug is d. It can be given if repeated best determined by which of the following? doses required a. Efficacy of the drug used e. There is no risk of b. Potency of the drug used aspiration of drug c. Therapeutic index of the 44. To calculate the loading dose of a drug, drug when the desired steady state concentration d. Graded dose response curve e. Quantal dose response curve 49. Half life of a drug may be helpful to determine a a. Dosage schedule of the drug b. Level of absorption c. Distribution into different body systems d. Rate of absorption through GIT e. Time to get the steady state. 50. The steady state concentration of a drug can be doubled by a. Doubling both rate of infusion and conc. b. Doubling the rate of infusion only c. Doubling loading dose d. Tripling the rate of infusion e. Quadrupling the rate of infusion